JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, R. L.
Right arrow Articles by Hanck, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, R. L.
Right arrow Articles by Hanck, D. A.

Vol. 295, Issue 1, 302-308, October 2000

Mibefradil Block of Cloned T-Type Calcium Channels1

Ruth L. Martin, Jung-Ha Lee, Leanne L. Cribbs, Edward Perez-Reyes and Dorothy A. Hanck

Department of Medicine, The University of Chicago, Chicago, Illinois (R.L.M., D.A.H.); Department of Physiology and Cardiovascular Institute, Loyola University of Chicago, Maywood, Illinois (L.L.C.); and Department of Physiology, University of Virginia, Charlottesville, Virginia (J.-H.L., E.P.-R.)

Mibefradil is a tetralol derivative chemically distinct from other calcium channel antagonists. It is a very effective antihypertensive agent that is thought to achieve its action via a higher affinity block for low-voltage-activated (T) than for high-voltage-activated (L) calcium channels. Estimates of affinity using Ba2+ as the charge carrier have predicted a 10- to 15-fold preference of mibefradil for T channels over L channels. However, T channel IC50 values are reported to be ~1 µM, which is much higher than expected for clinical efficacy because relevant blood levels of this drug are ~50 nM. We compared the affinity for mibefradil of the newly cloned T channel isoforms, alpha 1G, alpha 1H, and alpha 1I with an L channel, alpha 1C. In 10 mM Ba2+, mibefradil blocked in the micromolar range and with 12- to 13-fold greater affinity for T channels than for L channels (~1 µM versus 13 µM). When 2 mM Ca2+ was used as the charge carrier, the drug was more efficacious; the IC50 for alpha 1G shifted to 270 nM and for alpha 1H shifted to 140 nM, 4.5- and 9-fold higher affinity than in 10 mM Ba. The data are consistent with the idea that mibefradil competes for its binding site on the channel with the permeant species and that Ba2+ is a more effective competitor than Ca2+. Raising temperature to 35°C reduced affinity (IC50 792 nM). Reducing channel availability to half increased affinity (~70 nM). This profile of mibefradil affinity makes these channels good candidates for the physiological target of this antihypertensive agent.


1 This research was supported by the National Heart, Lung and Blood Institute, National Institutes of Health Grants HL-PO1-20592 (D.A.H.) and HL-58728 (E.P.-R.) and by a grant-in-aid from the American Heart Association to D.A.H.


0022-3565/00/2951-0302$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Moldobaeva, J. Jenkins, and E. Wagner
Effects of distension on airway inflammation and venular P-selectin expression
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L941 - L948.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. C. Major, S. Dhamija, N. Black, S. Liachenko, B. Morenko, G. Sobocinski, C. Okerberg, P. Tinholt, S. Madore, and M. C. Kowala
The T- and L-Type Calcium Channel Blocker (CCB) Mibefradil Attenuates Leg Edema Induced by the L-Type CCB Nifedipine in the Spontaneously Hypertensive Rat: A Novel Differentiating Assay
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 723 - 731.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Calixto, E. J. Galvan, J. P. Card, and G. Barrionuevo
Coincidence detection of convergent perforant path and mossy fibre inputs by CA3 interneurons
J. Physiol., June 1, 2008; 586(11): 2695 - 2712.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Alvina and K. Khodakhah
Selective regulation of spontaneous activity of neurons of the deep cerebellar nuclei by N-type calcium channels in juvenile rats
J. Physiol., May 15, 2008; 586(10): 2523 - 2538.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
I. Panek, U. Hoger, A. S. French, and P. H. Torkkeli
Contributions of Voltage- and Ca2+-Activated Conductances to GABA-Induced Depolarization in Spider Mechanosensory Neurons
J Neurophysiol, April 1, 2008; 99(4): 1596 - 1606.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Telemaque, S. Sonkusare, T. Grain, S. W. Rhee, J. R. Stimers, N. J. Rusch, and J. D. Marsh
Design of Mutant {beta}2 Subunits as Decoy Molecules to Reduce the Expression of Functional Ca2+ Channels in Cardiac Cells
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 37 - 46.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
O. Ibanez-Sandoval, L. Carrillo-Reid, E. Galarraga, D. Tapia, E. Mendoza, J. C. Gomora, J. Aceves, and J. Bargas
Bursting in Substantia Nigra Pars Reticulata Neurons In Vitro: Possible Relevance for Parkinson Disease
J Neurophysiol, October 1, 2007; 98(4): 2311 - 2323.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Ukhanov, T. Leinders-Zufall, and F. Zufall
Patch-Clamp Analysis of Gene-Targeted Vomeronasal Neurons Expressing a Defined V1r or V2r Receptor: Ionic Mechanisms Underlying Persistent Firing
J Neurophysiol, October 1, 2007; 98(4): 2357 - 2369.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S.-K. Yang, H. C. Parkington, J. Epelbaum, D. J. Keating, and C. Chen
Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1863 - E1870.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
G. Panyi and C. Deutsch
Probing the Cavity of the Slow Inactivated Conformation of Shaker Potassium Channels
J. Gen. Physiol., April 30, 2007; 129(5): 403 - 418.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Y. Kim and L. O. Trussell
Ion Channels Generating Complex Spikes in Cartwheel Cells of the Dorsal Cochlear Nucleus
J Neurophysiol, February 1, 2007; 97(2): 1705 - 1725.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
B. Coste, M. Crest, and P. Delmas
Pharmacological Dissection and Distribution of NaN/Nav1.9, T-type Ca2+ Currents, and Mechanically Activated Cation Currents in Different Populations of DRG Neurons
J. Gen. Physiol., January 1, 2007; 129(1): 57 - 77.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. McNulty, J. W. Kyle, G. M. Lipkind, and D. A. Hanck
An Inner Pore Residue (Asn406) in the Nav1.5 Channel Controls Slow Inactivation and Enhances Mibefradil Block to T-Type Ca2+ Channel Levels
Mol. Pharmacol., November 1, 2006; 70(5): 1514 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. S. Freeze, M. M. McNulty, and D. A. Hanck
State-Dependent Verapamil Block of the Cloned Human Cav3.1 T-Type Ca2+ Channel
Mol. Pharmacol., August 1, 2006; 70(2): 718 - 726.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. Khosravani and G. W. Zamponi
Voltage-gated calcium channels and idiopathic generalized epilepsies.
Physiol Rev, July 1, 2006; 86(3): 941 - 966.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Czirjak and P. Enyedi
Zinc and Mercuric Ions Distinguish TRESK from the Other Two-Pore-Domain K+ Channels
Mol. Pharmacol., March 1, 2006; 69(3): 1024 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. R. Strege, C. E. Bernard, Y. Ou, S. J. Gibbons, and G. Farrugia
Effect of mibefradil on sodium and calcium currents
Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G249 - G253.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. I. Brueggemann, B. L. Martin, J. Barakat, K. L. Byron, and L. L. Cribbs
Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H923 - H935.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Cui, T. Okamoto, and H. Morikawa
Spontaneous Opening of T-Type Ca2+ Channels Contributes to the Irregular Firing of Dopamine Neurons in Neonatal Rats
J. Neurosci., December 8, 2004; 24(49): 11079 - 11087.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. McNulty and D. A. Hanck
State-Dependent Mibefradil Block of Na+ Channels
Mol. Pharmacol., December 1, 2004; 66(6): 1652 - 1661.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. S. Chan, R. Shigemoto, J. N. Mercer, and D. J. Surmeier
HCN2 and HCN1 Channels Govern the Regularity of Autonomous Pacemaking and Synaptic Resetting in Globus Pallidus Neurons
J. Neurosci., November 3, 2004; 24(44): 9921 - 9932.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev, April 1, 2004; 84(2): 489 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Huang, B. M. Keyser, T. M. Tagmose, J. B. Hansen, J. T. Taylor, H. Zhuang, M. Zhang, D. S. Ragsdale, and M. Li
NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-Benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: A New Selective Inhibitor of T-Type Calcium Channels
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 193 - 199.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Cataldi, A. Gaudino, V. Lariccia, M. Russo, S. Amoroso, G. di Renzo, and L. Annunziato
Imatinib-Mesylate Blocks Recombinant T-Type Calcium Channels Expressed in Human Embryonic Kidney-293 Cells by a Protein Tyrosine Kinase-Independent Mechanism
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 208 - 215.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. Wu, J. Haynes Jr, J. T. Taylor, B. O. Obiako, J. R. Stubbs, M. Li, and T. Stevens
Cav3.1 ({alpha}1G) T-Type Ca2+ Channels Mediate Vaso-Occlusion of Sickled Erythrocytes in Lung Microcirculation
Circ. Res., August 22, 2003; 93(4): 346 - 353.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. K. Cloues and W. A. Sather
Afterhyperpolarization Regulates Firing Rate in Neurons of the Suprachiasmatic Nucleus
J. Neurosci., March 1, 2003; 23(5): 1593 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Perez-Reyes
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
Physiol Rev, January 1, 2003; 83(1): 117 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Hirooka, G. E. Bertolesi, M. E. M. Kelly, E. M. Denovan-Wright, X. Sun, J. Hamid, G. W. Zamponi, A. E. Juhasz, L. W. Haynes, and S. Barnes
T-Type Calcium Channel alpha 1G and alpha 1H Subunits in Human Retinoblastoma Cells and Their Loss After Differentiation
J Neurophysiol, July 1, 2002; 88(1): 196 - 205.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
J. C. Gomora, J. Murbartian, J. M. Arias, J.-H. Lee, and E. Perez-Reyes
Cloning and Expression of the Human T-Type Channel Cav3.3: Insights into Prepulse Facilitation
Biophys. J., July 1, 2002; 83(1): 229 - 241.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Wolfart and J. Roeper
Selective Coupling of T-Type Calcium Channels to SK Potassium Channels Prevents Intrinsic Bursting in Dopaminergic Midbrain Neurons
J. Neurosci., May 1, 2002; 22(9): 3404 - 3413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Mariot, K. Vanoverberghe, N. Lalevee, M. F. Rossier, and N. Prevarskaya
Overexpression of an alpha 1H (Cav3.2) T-type Calcium Channel during Neuroendocrine Differentiation of Human Prostate Cancer Cells
J. Biol. Chem., March 22, 2002; 277(13): 10824 - 10833.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Michels, J. Matthes, R. Handrock, U. Kuchinke, F. Groner, L. L. Cribbs, A. Pereverzev, T. Schneider, E. Perez-Reyes, and S. Herzig
Single-Channel Pharmacology of Mibefradil in Human Native T-Type and Recombinant Cav3.2 Calcium Channels
Mol. Pharmacol., March 1, 2002; 61(3): 682 - 694.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. M. Todorovic, V. Jevtovic-Todorovic, S. Mennerick, E. Perez-Reyes, and C. F. Zorumski
Cav3.2 Channel Is a Molecular Substrate for Inhibition of T-Type Calcium Currents in Rat Sensory Neurons by Nitrous Oxide
Mol. Pharmacol., September 1, 2001; 60(3): 603 - 610.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.